Published online before print June 4, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
,
,
Departments of *Pharmacology and
Toxicology, Hannover Medical School, Hannover, Germany; and
Amgen SF, LLC, South San Francisco, California, USA
@ To whom correspondence should be addressed. E-mail: Neumann.Detlef{at}MH-Hannover.de.
Ligand binding in the TLR/IL-1R family results in the transient formation of an intracellular signaling complex, which contains, amongst others, the serine/threonine-specific kinase IL-1R-associated kinase 1 (IRAK-1). Concomitantly, the kinase function of IRAK-1 becomes activated, resulting in massive autophosphorylation and finally in the dissociation of the initially constituted signaling complex. The death domain (DD) of IRAK-1 mediates the interaction with other molecules of the signaling complex, e.g., the adaptor MyD88, the silencer Tollip, and the activator kinase IRAK-4. The conserved threonine at position 66 (T66), located within the DD, is a putative autophosphorylation target site. Here, we provide evidence that T66 critically impacts the secondary structure of the IRAK-1 DD. Thereby, it ensures the transient manner of interactions between IRAK-1 and the other signaling molecules. This essential role, however, is not regulated by phosphorylation of T66 itself.
Key Words: inflammation kinases interleukin-1 Toll-like receptor Tollip